Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Pharmacotherapy in patients with epilepsy and psychosis.

de Toffol B, Trimble M, Hesdorffer DC, Taylor L, Sachdev P, Clancy M, Adachi N, Bragatti JA, Mula M, Kanemoto K.

Epilepsy Behav. 2018 Sep 18;88:54-60. doi: 10.1016/j.yebeh.2018.09.001. [Epub ahead of print] Review.

PMID:
30241054
2.

A review of clinical characteristics and genetic backgrounds in Alport syndrome.

Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, Kaito H, Kanemoto K, Kobayashi A, Tanaka E, Tanaka K, Hama T, Fujimaru R, Miwa S, Yamamura T, Yamamura N, Horinouchi T, Minamikawa S, Nagata M, Iijima K.

Clin Exp Nephrol. 2018 Aug 20. doi: 10.1007/s10157-018-1629-4. [Epub ahead of print]

PMID:
30128941
3.

Thiamine Concentrations in Newly Hospitalized Elderly Patients with Infectious Diseases at a Community Hospital in Japan.

Akashi Y, Suzuki H, Kanemoto K, Hirose Y, Yamashita K, Yamamoto T, Miyazawa T, Hirose K, Ishikawa H, Maeno T.

J Nutr Sci Vitaminol (Tokyo). 2018;64(3):209-214. doi: 10.3177/jnsv.64.209.

4.

Long-latency suppression of auditory and somatosensory change-related cortical responses.

Takeuchi N, Sugiyama S, Inui K, Kanemoto K, Nishihara M.

PLoS One. 2018 Jun 26;13(6):e0199614. doi: 10.1371/journal.pone.0199614. eCollection 2018.

5.

[Evaluation of a Two-day Hospital On-site Training Program for Community Pharmacists: Approach to Facilitate Collaboration among Community Healthcare Professionals].

Sumi M, Hasegawa C, Morii H, Hoshino N, Okunuki Y, Kanemoto K, Horie M, Okamoto H, Yabuta N, Matsuda M, Kamiya T, Sudo M, Masuda K, Iwashita Y, Matsuda K, Motooka Y, Hira D, Morita SY, Terada T.

Yakugaku Zasshi. 2018;138(5):715-722. doi: 10.1248/yakushi.17-00212. Japanese.

6.

Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.

Mushiroda T, Takahashi Y, Onuma T, Yamamoto Y, Kamei T, Hoshida T, Takeuchi K, Otsuka K, Okazaki M, Watanabe M, Kanemoto K, Oshima T, Watanabe A, Minami S, Saito K, Tanii H, Shimo Y, Hara M, Saitoh S, Kinoshita T, Kato M, Yamada N, Akamatsu N, Fukuchi T, Ishida S, Yasumoto S, Takahashi A, Ozeki T, Furuta T, Saito Y, Izumida N, Kano Y, Shiohara T, Kubo M; GENCAT Study Group.

JAMA Neurol. 2018 Jul 1;75(7):842-849. doi: 10.1001/jamaneurol.2018.0278.

PMID:
29610831
7.

PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps-an ILAE PNES Task Force report.

Kanemoto K, LaFrance WC Jr, Duncan R, Gigineishvili D, Park SP, Tadokoro Y, Ikeda H, Paul R, Zhou D, Taniguchi G, Kerr M, Oshima T, Jin K, Reuber M.

Epilepsia Open. 2017 Jun 23;2(3):307-316. doi: 10.1002/epi4.12060. eCollection 2017 Sep.

8.

Depression in people with epilepsy: How much do Asian colleagues acknowledge it?

Asadi-Pooya AA, Kanemoto K, Kwon OY, Taniguchi G, Dong Z, Chinvarun Y, Yu HY, McGonigal A, Kanner AM, Park SP.

Seizure. 2018 Apr;57:45-49. doi: 10.1016/j.seizure.2018.03.012. Epub 2018 Mar 12. Review.

PMID:
29562209
9.

Computational study on formation of 15-membered azalactone by double reductive amination using molecular mechanics and density functional theory calculations.

Gouda H, Nakayama N, Miura T, Kanemoto K, Ajito K.

J Antibiot (Tokyo). 2018 May;71(5):549-556. doi: 10.1038/s41429-018-0030-6. Epub 2018 Mar 7.

PMID:
29515229
10.

Risk of hospitalization associated with anticholinergic medication for patients with dementia.

Watanabe S, Fukatsu T, Kanemoto K.

Psychogeriatrics. 2018 Jan;18(1):57-63. doi: 10.1111/psyg.12291.

PMID:
29372598
11.

[Diagnosis of Psychogenic Non-Epileptic Seizure: How Can We Detect It Prior to Video-Electroencephalography Monitoring].

Kanemoto K.

Brain Nerve. 2017 Dec;69(12):1401-1408. doi: 10.11477/mf.1416200925. Japanese.

PMID:
29282343
12.

Access to diagnostic and therapeutic facilities for psychogenic nonepileptic seizures: An international survey by the ILAE PNES Task Force

Hingray C, El-Hage W, Duncan R, Gigineishvili D, Kanemoto K, LaFrance WC Jr, de Marinis A, Paul R, Pretorius C, Téllez-Zenteno JF, Wiseman H, Reuber M.

Epilepsia. 2018 Jan;59(1):203-214. doi: 10.1111/epi.13952. Epub 2017 Nov 20. Erratum in: Epilepsia. 2018 Feb;59(2):507.

PMID:
29152734
13.

Rhodium-catalyzed odorless synthesis of diaryl sulfides from borylarenes and S-aryl thiosulfonates.

Kanemoto K, Sugimura Y, Shimizu S, Yoshida S, Hosoya T.

Chem Commun (Camb). 2017 Sep 26;53(77):10640-10643. doi: 10.1039/c7cc05868c.

PMID:
28920976
14.

Efficacy of a third or later antiepileptic drug regimen according to epilepsy syndrome among adult patients.

Ito G, Okumura A, Kanemoto K.

Epilepsy Res. 2017 Oct;136:103-108. doi: 10.1016/j.eplepsyres.2017.07.018. Epub 2017 Aug 3.

PMID:
28822307
15.

Identifying species threat hotspots from global supply chains.

Moran D, Kanemoto K.

Nat Ecol Evol. 2017 Jan 4;1(1):23. doi: 10.1038/s41559-016-0023.

PMID:
28812571
16.

True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires.

Anzai H, Suzuki M, Nagashima K, Kanai M, Zhu Z, He Y, Boudot M, Zhang G, Takahashi T, Kanemoto K, Seki T, Shibata N, Yanagida T.

Nano Lett. 2017 Aug 9;17(8):4698-4705. doi: 10.1021/acs.nanolett.7b01362. Epub 2017 Jul 7.

PMID:
28671477
17.

Obsessive-Compulsive Disorder Associated with Posterior Cranial Fossa Meningioma.

Takeuchi N, Kato E, Kanemoto K.

Case Rep Psychiatry. 2017;2017:8164537. doi: 10.1155/2017/8164537. Epub 2017 Jun 1.

18.

New paradigm for auditory paired pulse suppression.

Takeuchi N, Sugiyama S, Inui K, Kanemoto K, Nishihara M.

PLoS One. 2017 May 18;12(5):e0177747. doi: 10.1371/journal.pone.0177747. eCollection 2017.

19.

Pre- and post-surgical psychiatric assessments and intervention by major epilepsy centers in Japan - Nationwide survey.

Goji H, Fukuchi T, Kanemoto K.

Epilepsy Behav. 2017 May;70(Pt A):61-65. doi: 10.1016/j.yebeh.2017.02.017. Epub 2017 Apr 12.

PMID:
28411517
20.

Resource footprints and their ecosystem consequences.

Verones F, Moran D, Stadler K, Kanemoto K, Wood R.

Sci Rep. 2017 Jan 23;7:40743. doi: 10.1038/srep40743.

Supplemental Content

Loading ...
Support Center